IQ-AI LTD. LS -01

Research IQ-AI LTD. LS -01 (5Y1) on Bullrun: market cap EUR 123.35K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 123.35K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 788.15K-GBP 400.94K-GBP 190.06K93.5%0GBP 112.61Kn/aGBP 407.62K
FY2024GBP 750.11K-GBP 327.10K-GBP 445.14K99.0%0GBP 53.50Kn/aGBP 302.53K
FY2023GBP 609.39K-GBP 623.82K-GBP 175.23K98.1%0GBP 138.75KGBP 0GBP 94.92K
FY2022GBP 535.89K-GBP 511.60K-GBP 414.60K99.7%0GBP 313.99KGBP 0GBP 707.07K
FY2021GBP 521.07K-GBP 501.06K-GBP 345.32K96.7%0GBP 728.59KGBP 55.41KGBP 1.19M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 123.35Kn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About IQ-AI LTD. LS -01

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro, an MRI perfusion platform that generates quantitative relative cerebral blood volume maps;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is IQ-AI LTD. LS -01's market cap?

IQ-AI LTD. LS -01's market capitalization is EUR 123.35K.

What does IQ-AI LTD. LS -01 do?

Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments.